Risk Factors for Postpartum Antihypertensive Medication Requirement in Severe Preeclampsia
Authors:
- 29 July 2010
- journal article
- research article
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 29 (3) , 350-356
Abstract
Objective: To determine antepartum risk factors for postpartum antihypertensive medication use in women with severe preeclampsia. Methods: A case control study was performed on patients who were diagnosed with severe preeclampsia between January 2000 and June 2004 at a single tertiary care center. Women discharged from the hospital on antihypertensive medications were compared to women discharged home on no antihypertensive medications. Demographic data, maternal medical conditions, and delivery data were abstracted from maternal charts. Risk factors were evaluated using multiple logistic regression. Results: 218 patients with severe preeclampsia were identified, of which 112 were discharged on antihypertensives. After adjusting for confounding variables, chronic hypertension was associated with an increased need for post partum antihypertensive medication (OR 7.5 (95% CI 3.0–18.1)). A dose-dependent association was seen with intrapartum hydralazine administration. High-dose hydralazine was associated with increased need for postpartum antihypertensive mediation (OR 5.74 95% CI 2.03–16.2) compared to low-dose hydralazine (OR of 2.51 95% CI 1.26–5.01). Hemolysis/Elevated liver function/low platelet (HELLP) syndrome was associated with a decreased need for antihypertensive medication (OR 0.33, 95% CI 0.13–0.82). Conclusions: Patients with chronic hypertension and patients who required intrapartum hydralazine were more likely to require antihypertensive medications at discharge.Keywords
This publication has 13 references indexed in Scilit:
- Remodelling of Small Resistance Arteries in Essential HypertensionHigh Blood Pressure & Cardiovascular Prevention, 2006
- A prospective randomized trial of magnesium sulfate in severe preeclampsia: Use of diuresis as a clinical parameter to determine the duration of postpartum therapyAmerican Journal of Obstetrics and Gynecology, 2005
- Postpartum Preeclampsia Management With Furosemide: A Randomized Clinical TrialObstetrics & Gynecology, 2005
- Diagnosis and Management of Gestational Hypertension and PreeclampsiaObstetrics & Gynecology, 2003
- Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapyObstetrics & Gynecology, 2003
- Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndromeAmerican Journal of Obstetrics and Gynecology, 2000
- The myths of laparoscopic surgeryAmerican Journal of Obstetrics and Gynecology, 2000
- Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic HypertensionNew England Journal of Medicine, 1998
- The duration of hypertension in the puerperium of preeclamptic women: Relationship with renal impairment and week of deliveryAmerican Journal of Obstetrics and Gynecology, 1994
- HYPERTENSION IN THE PUERPERIUMThe Lancet, 1987